ArticleJournal of molecular modeling2008
Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors.
Article in Journal of molecular modeling, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.Drug discovery today · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
TIBO (Tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone) compounds are potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) that show a great promise for the treatment of AIDS. A structure-based molecular modeling approach based on template-based flexible docking simulation followed by 'Tabu clustering' was performed on a series of 46 TIBO derivatives considered as training set of HIV-1 NNRTIs. Four different templates of the highest active ligand (pIC(50) = 8.52) of the series were used. The results were reasonably satisfactory. A good correlation was observed between the biological activity and binding affinity of the compounds, which suggest that identified binding conformations of these inhibitors are reliable. Statistical modeling yielded satisfactory results (r(2) = 0.878). Our studies suggest that template-based docking followed by 'Tabu clustering' enhances the docking efficiency. Also, cross-validation with a test-set containing 16 compounds gave satisfactory results (r(2) = 0.836). Data mining of PubChem database yielded a total of 31 hits (25 novel TIBO like compounds, as well as, 6 novel scaffolds) with enhanced binding efficacy as hits. These hits may, be targeted toward potent lead-optimization and, help in designing and synthesizing novel compounds with enhanced therapeutic efficacy.
Indexed as
Identifiers
18642033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.